Replies to post #220435 on Biotech Values

[DewDiligence]

ENTA’s pro forma cash at 9/30/18=$380.8M, an increase of $32.7M since 6/30/18 (#msg-142808169).

The $380.8M figure above consists of: $364.4 of net current assets on the 9/30/18 balance sheet (https://www.sec.gov/Archives/edgar/data/1177648/000156459018030275/enta-10k_20180930.htm#CONSOLIDATED_BALANCE_SHEETS ); and $16.4M of marketable securities on the 9/30/18 balance sheet designated as non-current (e.g. US Treasury securities with a maturity of more than 1 year).